Carcinoid syndrome historical perspective: Difference between revisions
Jump to navigation
Jump to search
Ahmed Younes (talk | contribs) No edit summary |
Ahmed Younes (talk | contribs) No edit summary |
||
| Line 4: | Line 4: | ||
==Overview== | ==Overview== | ||
The term [[Carcinoid]] was given by | The term [[Carcinoid]] was given by Siegfried Oberndorfer, a German [[pathologist]] at the University of [[Munich]] in 1907. [[Enterochromaffin cell]], the [[cell]] of origin of [[carcinoid]] [[tumour]] had been identified as early as 1897 by N. [[Kulchitsky cells|Kulchitsky]]. | ||
==Historical Perspective== | ==Historical Perspective== | ||
* Theodor Langhans (1839–1915) was the first to describe the [[histology]] of a [[carcinoid tumor]] in 1867. | * Theodor Langhans (1839–1915) was the first to describe the [[histology]] of a [[carcinoid tumor]] in 1867. | ||
* The term [[Carcinoid]] was given by Siegfried Oberndorfer, a German [[pathologist]] at the University of Munich in 1907. | * The term [[Carcinoid]] was given by Siegfried Oberndorfer, a German [[pathologist]] at the University of Munich in 1907. | ||
* Siegfried Oberndorfer referred the [[carcinoid tumor]] as "[[benign]] [[Carcinomas|carcinomas"]] as they had distinct clinical entities and named them " | * Siegfried Oberndorfer referred the [[carcinoid tumor]] as "[[benign]] [[Carcinomas|carcinomas"]] as they had distinct clinical entities and named them "karzinoide"[[Carcinoma|(carcinoma]]-like). | ||
* Karzinoide or “[[carcinoma]]-like” describes the unique feature of behaving like a [[benign]] [[tumor]] despite resembling a [[carcinoma]] microscopically. | * Karzinoide or “[[carcinoma]]-like” describes the unique feature of behaving like a [[benign]] [[tumor]] despite resembling a [[carcinoma]] microscopically. | ||
* Rapport and colleagues isolated and named [[serotonin]] [[5-HT|(5-HT]]), initially identified as a [[vasoconstrictor]] [[substance]] in the [[serum]].<ref name="pmid18100415">{{cite journal |vauthors=RAPPORT MM, GREEN AA, PAGE IH |title=Serum vasoconstrictor, serotonin; isolation and characterization |journal=J. Biol. Chem. |volume=176 |issue=3 |pages=1243–51 |date=December 1948 |pmid=18100415 |doi= |url=}}</ref> | * Rapport and colleagues isolated and named [[serotonin]] [[5-HT|(5-HT]]), initially identified as a [[vasoconstrictor]] [[substance]] in the [[serum]].<ref name="pmid18100415">{{cite journal |vauthors=RAPPORT MM, GREEN AA, PAGE IH |title=Serum vasoconstrictor, serotonin; isolation and characterization |journal=J. Biol. Chem. |volume=176 |issue=3 |pages=1243–51 |date=December 1948 |pmid=18100415 |doi= |url=}}</ref> | ||
Revision as of 20:50, 30 April 2019
|
Carcinoid syndrome Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Carcinoid syndrome historical perspective On the Web |
|
American Roentgen Ray Society Images of Carcinoid syndrome historical perspective |
|
Risk calculators and risk factors for Carcinoid syndrome historical perspective |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Parminder Dhingra, M.D. [2]
Overview
The term Carcinoid was given by Siegfried Oberndorfer, a German pathologist at the University of Munich in 1907. Enterochromaffin cell, the cell of origin of carcinoid tumour had been identified as early as 1897 by N. Kulchitsky.
Historical Perspective
- Theodor Langhans (1839–1915) was the first to describe the histology of a carcinoid tumor in 1867.
- The term Carcinoid was given by Siegfried Oberndorfer, a German pathologist at the University of Munich in 1907.
- Siegfried Oberndorfer referred the carcinoid tumor as "benign carcinomas" as they had distinct clinical entities and named them "karzinoide"(carcinoma-like).
- Karzinoide or “carcinoma-like” describes the unique feature of behaving like a benign tumor despite resembling a carcinoma microscopically.
- Rapport and colleagues isolated and named serotonin (5-HT), initially identified as a vasoconstrictor substance in the serum.[1]
- Enterochromaffin cell,the cell of origin of carcinoid tumour had been identified as early as 1897 by N. Kulchitsky (1856-1925).
- F. Lembeck in 1953 established that enterochromaffin cells synthesizes and secretes serotonin and a major hormone responsible for carcinoid syndrome.[2][3]
References
- ↑ RAPPORT MM, GREEN AA, PAGE IH (December 1948). "Serum vasoconstrictor, serotonin; isolation and characterization". J. Biol. Chem. 176 (3): 1243–51. PMID 18100415.
- ↑ ERSPAMER V, ASERO B (May 1952). "Identification of enteramine, the specific hormone of the enterochromaffin cell system, as 5-hydroxytryptamine". Nature. 169 (4306): 800–1. PMID 14941051.
- ↑ Sippel RS, Chen H (July 2006). "Carcinoid tumors". Surg. Oncol. Clin. N. Am. 15 (3): 463–78. doi:10.1016/j.soc.2006.05.002. PMID 16882492.